Free Trial

Merck KGaA (OTCMKTS:MKKGY) Short Interest Down 98.1% in February

Merck KGaA logo with Medical background
Remove Ads

Merck KGaA (OTCMKTS:MKKGY - Get Free Report) was the recipient of a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 1,000 shares, a decline of 98.1% from the January 31st total of 53,500 shares. Based on an average daily volume of 176,700 shares, the short-interest ratio is presently 0.0 days.

Merck KGaA Stock Performance

Shares of Merck KGaA stock traded up $0.75 during trading on Monday, hitting $28.96. 129,146 shares of the stock were exchanged, compared to its average volume of 137,316. The stock's fifty day moving average is $29.19 and its 200 day moving average is $32.11. The stock has a market cap of $18.71 billion, a PE ratio of 17.88, a P/E/G ratio of 2.05 and a beta of 0.95. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33. Merck KGaA has a 12 month low of $27.68 and a 12 month high of $39.17.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Read More

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing
Is There Still Money in AI? How to Invest in the Next Big Wave

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads